MCK vs CI

For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.

2% revenue growth year-over-year, versus 11. 3% for Cigna Corporation (CI). Cigna Corporation (CI) offers the better valuation at 12. 7x trailing P/E (9. 3x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cigna Corporation (CI) is the cheapest at 12.

7x versus McKesson Corporation at 28. 9x. On forward P/E, Cigna Corporation is actually cheaper at 9. 3x.

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +308.

4%, compared to +19. 7% for Cigna Corporation (CI). Over 10 years, the gap is even starker: MCK returned +351. 9% versus CI's +135. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.

04β versus Cigna Corporation's 0. 35β — meaning CI is approximately 723% more volatile than MCK relative to the S&P 500.

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.

2% versus 11. 3% for Cigna Corporation (CI). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to 14. 9% for McKesson Corporation. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cigna Corporation (CI) is the more profitable company, earning 2.

2% net margin versus 0. 9% for McKesson Corporation — meaning it keeps 2. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CI leads at 3. 3% versus 1. 2% for MCK. At the gross margin level — before operating expenses — CI leads at 9. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Cigna Corporation (CI) trades at 9.

3x forward P/E versus 19. 1x for McKesson Corporation — 9. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MCK: 35. 3% to $1006. 50.

All stocks in this comparison pay dividends.

Cigna Corporation (CI) offers the highest yield at 2. 1%, versus 0. 4% for McKesson Corporation (MCK).

For long-horizon retirement investors, Cigna Corporation (CI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

35), 2. 1% yield, +135. 9% 10Y return). Both have compounded well over 10 years (CI: +135. 9%, MCK: +351. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MCK is a mid-cap high-growth stock; CI is a mid-cap deep-value stock. CI pays a dividend while MCK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.